Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-DOPA and Social Skills Training for Social Anhedonia in ASD
NCT03243552Phase 2Unknown
- Sponsor
- University of California, Los Angeles
- Start
- Jun 2017
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of levodopa in Autism Spectrum Disorder (ASD) (3 arms), sponsored by University of California, Los Angeles. Primary endpoint: Change in fMRI: Social Reward Task at week 16. Status: unknown.
02
Drugs
levodopa
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT03243552.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03243552.